Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Background/objectives Reduced consumption of trans-fatty acids (TFA) is desirable to lower coronary heart disease (CHD) risk. In practice, partially hydrogenated vegetable oils (PHVO) that contain both TFAs and other fatty acids are the unit of replacement and could be replaced with diverse alternative fats and oils. We performed quantitative estimates of CHD effects if a person's PHVO consumption were to be replaced with alternative fats and oils based on (1) randomized dietary trials and (2) prospective observational studies.Subjects/methods We performed meta-analyses of (1) the effects of TFAs on blood lipids and lipoproteins in controlled dietary trials and (2) associations of habitual TFA consumption with CHD outcomes in prospective cohort studies. On the basis of these results and corresponding findings for saturated fatty acids (SFA), cis-monounsaturated fatty acids (MUFA) and cis-polyunsaturated fatty acids (PUFA), we calculated the effects on CHD risk for replacing 7.5% of energy from three different PHVO formulations (containing 20, 35 or 45% TFAs) with butter, lard, palm or vegetable oils.Results In controlled trials, each 1% energy replacement of TFAs with SFAs, MUFAs or PUFAs, respectively, decreased the total cholesterol (TC)/high-density lipoprotein cholesterol (HDL-C) ratio by 0.31, 0.54 and 0.67; the apolipoprotein (Apo)-B/ApoAI ratio by 0.007, 0.010 and 0.011; and lipoprotein (Lp)(a) by 3.76, 1.39 and 1.11 mg/l (P<0.05 for each). We also included possible effects on C-reactive protein (CRP) of TFAs vs other fats from one trial. On the basis of these risk factor changes in controlled trials, CHD risk would be variably decreased by different fats and oils replacing 7.5% of energy from 20% TFA PHVO (CHD risk reduction: -2.7% (butter) to -9.9% (canola)); 35% TFA PHVO (-11.9% (butter) to -16.0% (canola)); or 45% TFA PHVO (-17.6% (butter) to -19.8% (canola)). In prospective cohort studies, each 2% energy replacement of TFAs with SFAs, MUFAs or PUFAs would lower CHD risk by 17% (95% confidence interval (CI)=7-25%), 21% (95% CI=12-30%) or 24% (95% CI=15-33%), respectively. On the basis of these associations in observational studies, CHD risk would be variably decreased by different fats and oils replacing 7.5% of energy from 20% TFA PHVO (CHD risk reduction: +0.5% (butter) to -21.8% (soybean)); 35% TFA PHVO (-14.4% (butter) to -33.4% (soybean)); or 45% TFA PHVO (-22.4% (butter) to -39.6% (soybean)). The demonstrated effects on TC/HDL-C, ApoB/ApoAI, Lp(a), and CRP in randomized feeding trials together accounted for approximately 65-80% and approximately 50% of the estimated risk reduction for replacing PHVO with animal fats and vegetable oils, respectively, that would be calculated from prospective cohort studies.Conclusions Effects on CHD risk of removing PHVO from a person's diet vary depending on the TFA content of the PHVO and the fatty acid composition of the replacement fat or oil, with direct implications for reformulation of individual food products. Accounting for the summed effects of TFAs on multiple CHD risk factors provides more accurate estimates of potential risk reduction than considering each risk factor in isolation, and approaches the estimated risk reduction derived from prospective cohort studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Replacing 1% energy of trans fatty acids with saturated, monounsaturated, or polyunsaturated fatty acids decreases the total cholesterol/HDL cholesterol ratio by 0.31, 0.54, and 0.67, respectively.283”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [283]
In the citing paper
“Substituting calories from mono- or poly-unsaturated fat with trans fatty acids increases LDL cholesterol, apolipoprotein B, triglycerides, and lipoprotein(a), and lowers plasma high-density lipoprotein cholesterol and apolipoprotein A1 levels (44).”
From Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms (2018) · cites this paper as [44]
In the citing paper
“Weight loss has a beneficial effect on lipids and lipoproteins.”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [385]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Summary estimates were obtained using random effects meta-analysis weighted by the inverse variance log RRs of the individual studies (DerSimonian and Laird, 1986).”
MethodYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953 · cited 2×
“For an estimated 1.2 mg/l higher CRP, the RR was 1.58 (95% CI¼1.48–1.68) (Danesh et al., 2004).”
MethodInfluentialMensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 1×
“The effects on blood lipid concentrations of isocaloric changes between consumption of SFAs, MUFAs and PUFAs were calculated from a prior meta-analysis of randomized controlled dietary trials (Mensink et al., 2003).”
Method(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 3×
“For a 1.33 decrease in the TC/HDL-C ratio, the relative risk (RR) of CHD (weighted across age groups) was 0.61 (95% confidence interval (CI)¼0.55–0.69) after correction for regression dilution bias (Prospective Studies Collaboration, 2007).”
BackgroundMethodInfluentialDietary Fat Intake and the Risk of Coronary Heart Disease in Women
Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., Colditz, G. A., Rosner, B. A., Hennekens, C. H., & Willett, W. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372102 · Cited by 1,782
Trans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752 · cited 11×
“…controlled feeding trials and of associations of habitual TFA consumption with clinical endpoints in prospective cohort studies, the estimated effects on CHD risk of replacing TFAs with equivalent calories from carbohydrate or cis-unsaturated fats has been estimated (Mozaffarian et al., 2006).”
BackgroundResultInfluentialSelf-citationMensink, R. P., & Katan, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008163230703 · Cited by 1,424 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundIntake of trans fatty acids and risk of coronary heart disease among women
WILLETT, W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90350-p · Cited by 1,025 · cited 2×
“For example, the use of objective biomarkers of TFA consumption (for example, erythrocyte membrane levels) (Sun et al., 2007) reveals stronger associations between TFA intake and CHD risk than the use of dietary questionnaires (Willett et al., 1993; Hu et al., 1997; Oh et al., 2005).”
BackgroundLipoprotein(a) and Coronary Heart Disease: Meta-Analysis of Prospective Studies
Danesh, J., Collins, R., & Peto, R. (2000) · Circulation · doi:10.1161/01.cir.102.10.1082 · Cited by 938 · cited 2×
“…TC/HDL-C, ApoB/ApoAI, Lp(a) and CRP if 7.5% of energy from PHVO were replaced with alternative fats and oils were calculated using established relationships between these risk factors and the incidence of CHD (Danesh et al., 2000, 2004; Yusuf et al., 2004; Prospective Studies Collaboration, 2007).”
BackgroundMethodInfluentialKinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Health effects of trans-fatty acids: experimental and observational evidence
Mozaffarian, D., Aro, A., & Willett, W. C. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602973 · Cited by 662 · cited 9×
“cardiovascular risk factors and is associated with higher risk of coronary heart disease (CHD) (Mozaffarian et al., 2009).”
BackgroundMethodInfluentialSelf-citationDietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies
Clarke, R., Frost, C., Collins, R., Appleby, P., & Peto, R. (1997) · BMJ · doi:10.1136/bmj.314.7074.112 · Cited by 644
Self-citationPietinen, P., Ascherio, A., Korhonen, P., Hartman, A. M., Willett, W. C., Albanes, D., & Virtamo, J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009047 · Cited by 557 · cited 2×
“…relationships with CHD risk were seen in two studies that utilized prospective updating of dietary habits by means of serial questionnaires over time (Oh et al., 2005; Mozaffarian et al., 2006), compared with the study in which dietary habits were assessed only at baseline (Pietinen et al., 1997).”
BackgroundResultOh, K. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi085 · Cited by 499 · cited 6×
“, 2007) reveals stronger associations between TFA intake and CHD risk than the use of dietary questionnaires (Willett et al., 1993; Hu et al., 1997; Oh et al., 2005).”
BackgroundResultInfluentialOomen, C. M., Ocké, M. C., Feskens, E. J., Erp-Baart, M.-A. J. V., Kok, F. J., & Kromhout, D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04166-0 · Cited by 491 · cited 2×
“Effects of TFA replacement: clinical outcomes based on cohort studies Four prospective cohort studies reporting on the association of habitual dietary consumption of TFAs with incidence of CHD events were identified (Figure 3) (Pietinen et al., 1997; Oomen et al., 2001; Oh et al., 2005; Mozaffarian et al., 2006).”
BackgroundBaer, D. J., Judd, J. T., Clevidence, B. A., & Tracy, R. P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.969 · Cited by 476 · cited 3×
“In the second trial (n¼50) (Baer et al., 2004), mean CRP levels were 1.27 mg/l following TFA consumption (8% of energy for 5 weeks), compared to 1.07 (Po0.”
BackgroundMethodInfluentialDietarytrans fatty acids: effects on plasma lipids and lipoproteins of healthy men and women
Judd, J., Clevidence, B., Muesing, R., Wittes, J., Sunkin, M., & Podczasy, J. (1994) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/59.4.861 · Cited by 457 · cited 1×
“…interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001;…”
BackgroundZock, P., & Katan, M. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41530-5 · Cited by 440
Summers, L. K. M., Fielding, B. A., Bradshaw, H. A., Ilic, V., Beysen, C., Clark, M. L., Moore, N. R., & Frayn, K. N. (2002) · Diabetologia · doi:10.1007/s00125-001-0768-3 · Cited by 414 · cited 2×
“In addition to effects on TC/HDL-C, ApoB/ApoAI, Lp(a) and CRP, cisunsaturated fats in vegetable oils may have beneficial effects on other pathways related to cardiovascular risk, such as insulin sensitivity (Summers et al., 2002; Paniagua et al., 2007) and endothelial function (Perez-Jimenez et al.”
BackgroundEffects of Different Forms of Dietary Hydrogenated Fats on Serum Lipoprotein Cholesterol Levels
Lichtenstein, A. H., Ausman, L. M., Jalbert, S. M., & Schaefer, E. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402501 · Cited by 352 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundGinsberg, H. N., Kris-Etherton, P., Dennis, B., Elmer, P. J., Ershow, A., Lefevre, M., Pearson, T., Roheim, P., Ramakrishnan, R., Reed, R., et al. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.3.441 · Cited by 294 · cited 1×
“This potential Lp(a) lowering effect of SFA has been seen previously (Ginsberg et al., 1998; Muller et al., 2003).”
BackgroundAro, A., Jauhiainen, M., Partanen, R., Salminen, I., & Mutanen, M. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1419 · Cited by 281 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundA Prospective Study of Trans Fatty Acids in Erythrocytes and Risk of Coronary Heart Disease
Sun, Q., Ma, J., Campos, H., Hankinson, S. E., Manson, J. E., Stampfer, M. J., Rexrode, K. M., Willett, W. C., & Hu, F. B. (2007) · Circulation · doi:10.1161/circulationaha.106.679985 · Cited by 246 · cited 2×
“For example, the use of objective biomarkers of TFA consumption (for example, erythrocyte membrane levels) (Sun et al., 2007) reveals stronger associations between TFA intake and CHD risk than the use of dietary questionnaires (Willett et al., 1993; Hu et al., 1997; Oh et al., 2005).”
BackgroundLovejoy, J. C., Smith, S. R., Champagne, C. M., Most, M. M., Lefevre, M., DeLany, J. P., Denkins, Y. M., Rood, J. C., Veldhuis, J., & Bray, G. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.8.1283 · Cited by 246 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundPaniagua, J. A., de la Sacristana, A. G., Sánchez, E., Romero, I., Vidal-Puig, A., Berral, F. J., Escribano, A., Moyano, M. J., Peréz-Martinez, P., López-Miranda, J., et al. (2007) · Journal of the American College of Nutrition · doi:10.1080/07315724.2007.10719633 · Cited by 227 · cited 2×
“In addition to effects on TC/HDL-C, ApoB/ApoAI, Lp(a) and CRP, cisunsaturated fats in vegetable oils may have beneficial effects on other pathways related to cardiovascular risk, such as insulin sensitivity (Summers et al., 2002; Paniagua et al., 2007) and endothelial function (Perez-Jimenez et al.”
BackgroundNicholls, S. J., Lundman, P., Harmer, J. A., Cutri, B., Griffiths, K. A., Rye, K.-A., Barter, P. J., & Celermajer, D. S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.080 · Cited by 217 · cited 2×
“, 2007) and endothelial function (Perez-Jimenez et al., 1999; Nicholls et al., 2006), in comparison with animal fats.”
BackgroundTrans fatty acids – Effects on systemic inflammation and endothelial function
Mozaffarian, D. (2006) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2006.04.007 · Cited by 212 · cited 1×
“This potential CRP-raising effect of TFA is consistent with observational studies of habitual TFA consumption (Mozaffarian, 2006).”
Self-citationEckel, R. H., Borra, S., Lichtenstein, A. H., & Yin-Piazza, S. Y. (2007) · Circulation · doi:10.1161/circulationaha.106.181947 · Cited by 194 · cited 3×
“diet (by reformulation of specific food items or cooking processes) could be replaced by several alternative fats and oils (Eckel et al., 2007), each comprising different combinations of SFAs, PUFAs and MUFAs.”
BackgroundAlmendingen, K., Jordal, O., Kierulf, P., Sandstad, B., & Pedersen, J. I. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41144-7 · Cited by 173
Approaches to removing trans fats from the food supply in industrialized and developing countries
L'Abbé, M. R., Stender, S., Skeaff, C. M., Ghafoorunissa, & Tavella, M. (2009) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.14 · Cited by 169 · cited 3×
“…is commonly used for home cooking; as a substitute for ghee; in the bakery industry and in preparation of commercially fried, processed, frozen, ready-to-eat and street foods; vanaspati is typically blended from PHVO and other oils and contains an average of 18–43% TFA (L’Abbe et al., 2009).”
BackgroundInfluentialLichtenstein, A. H., Erkkilä, A. T., Lamarche, B., Schwab, U. S., Jalbert, S. M., & Ausman, L. M. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.07.005 · Cited by 163 · cited 2×
“In one trial (n1⁄436), significant effects on CRP were not seen (Lichtenstein et al., 2003).”
Background(2005) · PubMed · Cited by 146
Self-citationDietary cis and trans monounsaturated and saturated FA and plasma lipids and lipoproteins in men
Judd, J. T., Baer, D. J., Clevidence, B. A., Kris‐Etherton, P., Muesing, R. A., & Iwane, M. (2002) · Lipids · doi:10.1007/s11745-002-0871-9 · Cited by 132 · cited 1×
“…interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001;…”
Backgroundde Roos, N. M., Schouten, E. G., & Katan, M. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.242 · Cited by 129 · cited 1×
“…involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovejoy et al., 2002; Sundram et al., 2007).”
BackgroundConsumption of trans fats and estimated effects on coronary heart disease in Iran
Mozaffarian, D., Abdollahi, M., Campos, H., Houshiarrad, A., & Willett, W. C. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602608 · Cited by 128 · cited 5×
“5% of total calories; the top two PHVO contain 34–36% TFA (Mozaffarian et al., 2007).”
BackgroundMethodInfluentialSelf-citationSundram, K., Karupaiah, T., & Hayes, K. C. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-3 · Cited by 124 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundCirculating levels of endothelial function are modulated by dietary monounsaturated fat
Pérez‐Jiménez, F., Castro, P., López‐Miranda, J., Paz-Rojas, E., Blanco, A., Lopez‐Segura, F., Velasco, F., Marín, C., Fuentes, F. J., & Ordovás, J. M. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00116-1 · Cited by 116 · cited 2×
“, 2007) and endothelial function (Perez-Jimenez et al., 1999; Nicholls et al., 2006), in comparison with animal fats.”
BackgroundJudd, J. T., Baer, D. J., Clevidence, B. A., Muesing, R. A., Chen, S. C., Weststrate, J. A., Meijer, G. W., Janet, W., Lichtenstein, A. H., Vilella-Bach, M., et al. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.4.768 · Cited by 111 · cited 1×
“…interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001;…”
BackgroundLightly hydrogenated soy oil versus other vegetable oils as a lipid-lowering dietary constituent
Laine, D. C., Snodgrass, C. M., Dawson, E. A., Ener, M. A., Kuba, K., & Frantz, I. D. (1982) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/35.4.683 · Cited by 66 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundFeasibility of recommending certain replacement or alternative fats
Skeaff, C. M. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602974 · Cited by 66 · cited 1×
“Compositions of other fats and oils are based on Eckel et al., 2007 and Skeaff, 2009.”
BackgroundMüller, H., Jordal, O., Kierulf, P., Kirkhus, B., & Pedersen, J. I. (1998) · Lipids · doi:10.1007/s11745-998-0284-9 · Cited by 52 · cited 2×
“included 66 dietary interventions (‘diets’) among men and women involving a total of 518 individuals (Laine et al., 1982; Mensink and Katan, 1990; Zock and Katan, 1992; Judd et al., 1994, 1998, 2002; Almendingen et al., 1995; Aro et al., 1997; Muller et al., 1998; Lichtenstein et al., 1999; de Roos et al., 2001; Lovej…”
BackgroundMüller, H., Lindman, A. S., Blomfeldt, A., Seljeflot, I., & Pedersen, J. I. (2003) · Journal of Nutrition · doi:10.1093/jn/133.11.3422 · Cited by 52 · cited 1×
“This potential Lp(a) lowering effect of SFA has been seen previously (Ginsberg et al., 1998; Muller et al., 2003).”
trans Fatty Acid Content of Canadian Margarines Prior to Mandatory trans Fat Labelling
Ratnayake, W. M. N., Gagnon, C., Dumais, L., Lillycrop, W., Wong, L. Y., Meleta, M., & Calway, P. (2007) · Journal of the American Oil Chemists Society · doi:10.1007/s11746-007-1112-y · Cited by 29 · cited 3×
“Similar amounts of TFAs are seen in PHVO stick margarines (mean 39% TFA (range 36–43%)) whereas PHVO soft (tub) margarines generally contain lower amounts of TFAs (mean 20% (range 17–33%)) (Ratnayake et al., 2007).”
BackgroundMethod
Cited by
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Authors/Task Force Members, Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,753
Danaei, G., Ding, E. L., Mozaffarian, D., Taylor, B., Rehm, J., Murray, C. J. L., & Ezzati, M. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000058 · Cited by 2,860
Self-citationEckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261
Metadata
- Authors
- Mozaffarian, D., & Clarke, R.
- Affiliations
- Brigham and Women's Hospital (US)
- University of Oxford (GB)
- Corresponding author
- Mozaffarian, D
- Venue
- European Journal of Clinical Nutrition
- Published
- 2009-05
- Volume
- 63
- Issue
- S2
- Pages
- S22-S33
- ISSN
- 0954-3007 (ISSN-L)
- 1476-5640
- OpenAlex
- W2053223480
- Cited by
- 410
- References
- 44
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 19 · 2023: 16 · 2022: 13 · 2021: 27 · 2020: 30 · 2019: 19 · 2018: 16 · 2017: 18 · 2016: 27 · 2015: 33 · 2014: 35 · 2013: 35 · 2012: 42
- FWCI
- 34.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fonterra Co-Operative Group
- National Institutes of Health (1k08hl075628-01)
- National Heart, Lung, and Blood Institute (K08-HL-075628)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- trans fatty acids, partially hydrogenated vegetable oils, coronary heart disease risk, fat replacement, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids, serum lipids, lipoproteins, apolipoprotein B/apolipoprotein A-I ratio, lipoprotein(a), C-reactive protein, butter, lard, palm oil, vegetable oils, canola
- MeSH terms
- Animals, C-Reactive Protein, Cardiovascular Diseases, Cholesterol, Coronary Disease, Dietary Fats, Fatty Acids, Humans, Hydrogenation, Lipids, Plant Oils, Risk Factors, Trans Fatty Acids, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.